✦ LIBER ✦

Terlipressin therapy with and without albumin for patients with hepatorenal syndrome: Results of a prospective, nonrandomized study

✍ Scribed by Ortega, R

Book ID: 122674611
Publisher: John Wiley and Sons
Year: 2002
Tongue: English
Weight: 194 KB
Volume: 36
Category: Article
ISSN: 0270-9139
DOI: 10.1016/S0270-9139(02)00101-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Terlipressin therapy with and without al

Terlipressin therapy with and without albumin for patients with hepatorenal syndrome: Results of a prospective, nonrandomized study

✍ Rolando Ortega; Pere Ginès; Juan Uriz; Andrés Cárdenas; Blas Calahorra; Dara De 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 197 KB

Study of terlipressin administration wit

Study of terlipressin administration with and without albumin in hepatorenal syndrome (HRS)

✍ Abulfutuh, Ashraf R.; Morsy, Mohammed; Solyman, Abd El Ghany; Hendawy, Said El; 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 255 KB

Terlipressin and Albumin vs Albumin in P

Terlipressin and Albumin vs Albumin in Patients With Cirrhosis and Hepatorenal Syndrome: A Randomized Study

✍ Marta Martín–Llahí; Marie–Noëlle Pépin; Mónica Guevara; Fernando Díaz; Aldo Torr 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 339 KB

Effects of terlipressin administration w

Effects of terlipressin administration with and without albumin in hepatorenal syndrome (HRS). A phase II study

✍ R. Ortega; P. Gines; J. Uriz; B. Calahorra; A. Cardenas; D. De Las Heras; M. Gue 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 146 KB

311 TERLIPRESSIN AND ALBUMIN IN CIRRHOTI

311 TERLIPRESSIN AND ALBUMIN IN CIRRHOTIC PATIENTS WITH HEPATORENAL SYNDROME TYPE-1 WITH AND WITHOUT ACTIVE INFECTION

✍ M. Serrano-Romero; J.M. Pascasio; J.M. Sousa; A. Cayuela; M.T. Ferrer; E. Gómez- 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 65 KB

Predictors of response to therapy with t

Predictors of response to therapy with terlipressin and albumin in patients with cirrhosis and type 1 hepatorenal syndrome

✍ André Nazar; Gustavo Henrique Pereira; Mónica Guevara; Marta Martín-Llahi; Marie 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 169 KB 👁 1 views

Terlipressin plus albumin is an effective treatment for type 1 hepatorenal syndrome (HRS), but approximately only half of the patients respond to this therapy. The aim of this study was to assess predictive factors of response to treatment with terlipressin and albumin in patients with type 1 HRS. T